(Q36900364)

English

Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens

scientific article published on 20 July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

10

object named as

Hagop M Kantarjian

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Alessandra Ferrajoli

4

object named as

Alessandra Ferrajoli

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

8

object named as

Zeev Estrov

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

William G Wierda

3

object named as

William G Wierda

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Michael J. Keating

11

object named as

Michael J Keating

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Francesco C. Stingo

object named as

Francesco Stingo

5

1 reference

ORCID Public Data File 2021

7

object named as

Jan A Burger

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Susan M O'Brien

2

object named as

Susan M O'Brien

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Philip A Thompson

1

object named as

Philip A Thompson

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Susan C Smith

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Nitin Jain

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

0 references

publication date

20 July 2015

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

121

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

20

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

3612-3621

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4866653

29 September 2017

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4866653

29 September 2017

Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4866653

29 September 2017

Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4866653

29 September 2017

Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4866653

29 September 2017

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4866653

29 September 2017

Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4866653

29 September 2017

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4866653

29 September 2017

Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4866653

27 June 2018

Cytogenetic aspects of B-cell chronic lymphocytic leukemia: their correlation with clinical stage and different polyclonal mitogens.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4866653

27 June 2018

Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4866653

4 September 2018

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4866653

4 September 2018

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29566

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29566

21 January 2018

Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29566

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29566

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29566

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29566

7 January 2021

based on heuristic

inferred from DOI database lookup

Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26193999

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26193999

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses

1 reference

https://pubmed.ncbi.nlm.nih.gov/26193999

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.29566

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36900364&oldid=2088437363"